Kewaunee Scientific Corporation (KEQU)
KEQU trades on Nasdaq in Industrials, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$32.20
-0.62% on the day
Market cap
$93.2M
Micro cap
Revenue · 2025
$282.0M
+17.3% on 2024
Net income · 2025
$9.6M
3.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | KEQU on Nasdaq |
| Sector | Industrials |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000055529 |
| SEC industry code | Laboratory Apparatus & Furniture |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $282.0M |
| Net income | $9.6M |
| Operating income | $16.7M |
| Net margin | 3.4% |
| Operating margin | 5.9% |
| Revenue growth | +17.3% |
| Cash | $8.2M |
| Total assets | $176.0M |
| P/E (computed) | 9.7× |
| P/S (computed) | 0.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-06-26 |
| Latest quarterly / interim | 10-Q | 2026-09-11 |
| Latest current report | 8-K | 2026-09-09 |
| Latest proxy | DEFA14A | 2026-07-07 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SERA | Sera Prognostics Inc. | $2.04 | -1.45% | $80.5M |
| MDXH | MDxHealth SA | $0.6600 | +9.29% | $63.0M |
| BNR | Burning Rock Biotech Limited | $15.00 | 0.00% | $158.2M |
| XGN | Exagen Inc. | $8.48 | +2.79% | $205.4M |
| TLSI | TriSalus Life Sciences Inc. | $4.00 | -3.38% | $246.3M |
| BDSX | Biodesix Inc. | $25.00 | -2.72% | $263.8M |
| ACH | Accendra Health Inc. | $0.3151 | -19.31% | $24.2M |
| YDES | YD Bio Limited | $6.10 | -3.63% | $432.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier